MedTrace Logo

Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis

NCT04516577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 231

Last updated 2022-03-09

No results posted yet for this study

Summary

By updating the chest HRCT scoring criteria of patients with pulmonary alveolar proteinosis, a new and more perfect system for evaluating the severity of alveolar proteinosis will be established.

Conditions

  • Pulmonary Alveolar Proteinosis

Interventions

OTHER

Assesssing the severity of pulmonary alveolar proteinosis

Three severity scores will be used to assess the severity of patients with pulmonary alveolar proteinosis.

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    lead OTHER

Principal Investigators

  • Xinlun Tian, Dr · Peking Union Medical College Hospital

  • Yonglong Xiao, Dr · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04516577 on ClinicalTrials.gov